top of page
Search
Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury
This research was published in Laboratory Investigation: http://www.nature.com/labinvest/journal/v96/n6/full/labinvest201640a.html...
Glenn Hearson
Jul 14, 2016
The utility of exhaled nitric oxide in patients with suspected asthma
Published Asthma Research Study: "Reducing Costs in Asthma Management" The results from our "Reducing Costs in Asthma Management" study...
Glenn Hearson
Jul 1, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGFβ1 is considered central to the pa
Glenn Hearson
May 28, 2016
Low Exhaled Nitric Oxide in Asthma (FeNO)
New Asthma Research Study: LOW NO A clinical asthma research study, led by Prof Tim Harrison, to investigate if we can use a simple...
Glenn Hearson
May 26, 2016
Post authorisation safety study of Esbriet (PASSPORT)
Completed IPF Study Post authorisation Safety Study (PASS) of Esbriet® (Pirfenidone): A Prospective Observational Registry to Evaluate...
Glenn Hearson
May 5, 2016
Nottingham RRU COPD Research, Runner Up in CRN Awards
Our recent research study, Venous versus arterial sampling in exacerbations of COPD (VEVAS), PI Dr Dominick Shaw, came runner up in the...
Glenn Hearson
May 4, 2016
Community acquired pneumonia care bundle: results of a national implementation project
n 2013, 16 U.K. hospital trusts participated in a quality improvement programme involving implementation of a community-acquired pneumonia (
Glenn Hearson
May 4, 2016
Traditional and emerging indicators of cardiovascular risk in chronic obstructive pulmonary disease
We set out to assess CV risk parameters in well-characterized patients with COPD and controls with a smoking history using multiple approach
Glenn Hearson
Apr 22, 2016
bottom of page